Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth

San Diego, CA, December 12, 2024 (Business Wire) -- Pleno, Inc., a clinical and multi-omics diagnostics company, has appointed Dr. Vik Vaz, M.D., as Chief Executive Officer and Board Member to steer its commercialization phase following a successful $25 million Series B funding round. The funding was led by key investors Deerfield Management, Foresite Capital, and Medical Excellence Capital. Dr. Vaz brings extensive experience in life sciences, having previously led strategy and market intelligence at Illumina and worked as a partner at Boston Consulting Group and McKinsey & Company.

Read full article here.